D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease.
Peñas
P F
PF
Department of Dermatology, Hospital Universitario de la Princesa, Madrid, Spain.
Buezo
G F
GF
Carvajal
I
I
Daudén
E
E
López
A
A
Diaz
L A
LA
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis*; D015815:Cell Adhesion Molecules / Q000276:immunology*; D003598:Cytoskeletal Proteins / Q000276:immunology*; D051183:Desmoglein 1; D051182:Desmogleins; D051180:Desmoplakins; D005260:Female; D006801:Humans; D008947:Mixed Connective Tissue Disease / Q000188:drug therapy*; D010392:Pemphigus / Q000139:chemically induced* / Q000276:immunology; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use
D018501:Antirheumatic Agents; D001323:Autoantibodies; D015815:Cell Adhesion Molecules; D003598:Cytoskeletal Proteins; C495297:DSG1 protein, human; D051183:Desmoglein 1; D051182:Desmogleins; D051180:Desmoplakins; D010396:Penicillamine